Summary
C. R. Bard Inc (Bard) is a medical device company which designs, develops, manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices. It offers products related to vascular disorders, urology disorders, cancer diagnosis and treatment and surgical specialties. The company offers its comprehensive range of products to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company conducts its operations in Americas, Europe, Asia pacific, the Middle East and Africa. It has international manufacturing facilities in Puerto Rico, Germany, France, Belgium, Mexico and Malaysia. Bard is headquartered in Murray Hill, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company C. R. Bard Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
'
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
C. R. Bard Inc Company Overview 8
C. R. Bard Inc Company Snapshot 8
C. R. Bard Inc Pipeline Products and Ongoing Clinical Trials Overview 8
C. R. Bard Inc – Pipeline Analysis Overview 11
Business Description 11
C. R. Bard Inc - Key Facts 11
C. R. Bard Inc - Major Products and Services 12
C. R. Bard Inc Pipeline Products by Development Stage 14
C. R. Bard Inc Ongoing Clinical Trials by Trial Status 17
C. R. Bard Inc Pipeline Products Overview 19
Anti-Microbial Titanium PowerPort 19
Anti-Microbial Titanium PowerPort Product Overview 19
Anti-Thrombotic PICCs 20
Anti-Thrombotic PICCs Product Overview 20
Antimicrobial PICC 21
Antimicrobial PICC Product Overview 21
BARD HD MESH Mapper Catheter 22
BARD HD MESH Mapper Catheter Product Overview 22
Bard LifeStent 5F Vascular Stent System 23
Bard LifeStent 5F Vascular Stent System Product Overview 23
Bard LifeStent 5F Vascular Stent System Clinical Trial 24
Caterpillar 25
Caterpillar Product Overview 25
Covera Vascular Covered Stent Graft 26
Covera Vascular Covered Stent Graft Product Overview 26
COVERT PowerPICC 27
COVERT PowerPICC Product Overview 27
Dual Lumen PowerPort 28
Dual Lumen PowerPort Product Overview 28
ECHO 2.0 29
ECHO 2.0 Product Overview 29
EnCor Mini 30
EnCor Mini Product Overview 30
Fever Management Device 31
Fever Management Device Product Overview 31
Geo-Align Marking System 32
Geo-Align Marking System Product Overview 32
Internal Jugular Placement Catheter 33
Internal Jugular Placement Catheter Product Overview 33
Lifestream Stent Graft 34
Lifestream Stent Graft Product Overview 34
Loc Wire Replacement 35
Loc Wire Replacement Product Overview 35
Lutonix - AV 36
Lutonix - AV Product Overview 36
Lutonix - ISR 37
Lutonix - ISR Product Overview 37
Lutonix 014 DCB Catheter 38
Lutonix 014 DCB Catheter Product Overview 38
Lutonix 014 DCB Catheter Clinical Trial 39
LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions 41
LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions Product Overview 41
LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions Clinical Trial 42
Marquee 43
Marquee Product Overview 43
Minimally Invasive Cutting Instrumentation 44
Minimally Invasive Cutting Instrumentation Product Overview 44
New Fixation Device 45
New Fixation Device Product Overview 45
New Hemostat 1 46
New Hemostat 1 Product Overview 46
New Hemostat 2 47
New Hemostat 2 Product Overview 47
Next-generation Radiation Therapy 48
Next-generation Radiation Therapy Product Overview 48
Phasix Expansion 49
Phasix Expansion Product Overview 49
PowerPort - Low-Profile Version 50
PowerPort - Low-Profile Version Product Overview 50
Progel Dural Sealant 51
Progel Dural Sealant Product Overview 51
Progel Emerald 52
Progel Emerald Product Overview 52
ProGEL-VS 53
ProGEL-VS Product Overview 53
Restore Suturing System 54
Restore Suturing System Product Overview 54
RFID Tag Device 55
RFID Tag Device Product Overview 55
RFID Tag Device Clinical Trial 56
sideKicK Side Branch Protection System 57
sideKicK Side Branch Protection System Product Overview 57
Transformational Fixation 58
Transformational Fixation Product Overview 58
Tridyne Peripheral 59
Tridyne Peripheral Product Overview 59
Ultrascore 60
Ultrascore Product Overview 60
Venovo PTA Catheter 61
Venovo PTA Catheter Product Overview 61
VENOVO Venous Stent 62
VENOVO Venous Stent Product Overview 62
VIVEXX Carotid Stent 63
VIVEXX Carotid Stent Product Overview 63
XenMatrix AB LX 64
XenMatrix AB LX Product Overview 64
C. R. Bard Inc - Key Competitors 65
C. R. Bard Inc - Key Employees 66
C. R. Bard Inc - Key Employee Biographies 68
C. R. Bard Inc - Locations And Subsidiaries 69
Head Office 69
Other Locations & Subsidiaries 69
Business Unit 73
Recent Developments 74
C. R. Bard Inc, Recent Developments 74
Jan 30, 2017: Bard Peripheral Vascular Recalls Halo One Thin-Walled Guiding Sheath Due to Sheath Separation, Kinking, or Tip Damage 74
Jan 26, 2017: Bard Announces Fourth Quarter Results 74
Oct 25, 2016: Bard Announces Third Quarter Results 75
Sep 22, 2016: LUTONIX Global Real-World Registry 24-Month Outcomes Presented at VIVA 2016 75
Sep 19, 2016: FDA Approves 6-Month Primary End Point For The Lutonix Below-the-Knee Drug Coated Balloon 76
Jul 26, 2016: Bard Announces Second Quarter Results 76
Apr 27, 2016: Bard Announces First Quarter Results 77
Feb 09, 2016: New Real-World Comparison Showing Similar Efficacy Between the Lutonix and In.Pact Drug-Coated Balloons Featured at LINC 2016 78
Jan 29, 2016: Bard Announces Fourth Quarter Results 78
Jan 08, 2016: Seeger Weiss LLP Reports That IVC Filter Lawsuits Against C.R. Bard Have Been Consolidated In A Multidistrict Litigation 79
Appendix 80
Methodology 80
About GlobalData 82
Contact Us 82
Disclaimer 82
List of Tables
C. R. Bard Inc Pipeline Products and Ongoing Clinical Trials Overview 8
C. R. Bard Inc Pipeline Products by Equipment Type 9
C. R. Bard Inc Pipeline Products by Indication 10
C. R. Bard Inc Ongoing Clinical Trials by Trial Status 10
C. R. Bard Inc, Key Facts 11
C. R. Bard Inc, Major Products and Services 12
C. R. Bard Inc Number of Pipeline Products by Development Stage 14
C. R. Bard Inc Pipeline Products Summary by Development Stage 15
C. R. Bard Inc Ongoing Clinical Trials by Trial Status 17
C. R. Bard Inc Ongoing Clinical Trials Summary 18
Anti-Microbial Titanium PowerPort - Product Status 19
Anti-Microbial Titanium PowerPort - Product Description 19
Anti-Thrombotic PICCs - Product Status 20
Anti-Thrombotic PICCs - Product Description 20
Antimicrobial PICC - Product Status 21
Antimicrobial PICC - Product Description 21
BARD HD MESH Mapper Catheter - Product Status 22
BARD HD MESH Mapper Catheter - Product Description 22
Bard LifeStent 5F Vascular Stent System - Product Status 23
Bard LifeStent 5F Vascular Stent System - Product Description 23
Bard LifeStent 5F Vascular Stent System - A Prospective Study of the Performance of the Bard Lifestent 5F Vascular Stent System 24
Caterpillar - Product Status 25
Caterpillar - Product Description 25
Covera Vascular Covered Stent Graft - Product Status 26
Covera Vascular Covered Stent Graft - Product Description 26
COVERT PowerPICC - Product Status 27
COVERT PowerPICC - Product Description 27
Dual Lumen PowerPort - Product Status 28
Dual Lumen PowerPort - Product Description 28
ECHO 2.0 - Product Status 29
ECHO 2.0 - Product Description 29
EnCor Mini - Product Status 30
EnCor Mini - Product Description 30
Fever Management Device - Product Status 31
Fever Management Device - Product Description 31
Geo-Align Marking System - Product Status 32
Geo-Align Marking System - Product Description 32
Internal Jugular Placement Catheter - Product Status 33
Internal Jugular Placement Catheter - Product Description 33
Lifestream Stent Graft - Product Status 34
Lifestream Stent Graft - Product Description 34
Loc Wire Replacement - Product Status 35
Loc Wire Replacement - Product Description 35
Lutonix - AV - Product Status 36
Lutonix - AV - Product Description 36
Lutonix - ISR - Product Status 37
Lutonix - ISR - Product Description 37
Lutonix 014 DCB Catheter - Product Status 38
Lutonix 014 DCB Catheter - Product Description 38
Lutonix 014 DCB Catheter - A Prospective, Multicenter, Registry of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries (LEVANT 2 Safety Registry) 39
Lutonix 014 DCB Catheter - A Prospective, Multicenter, Single Arm Real-world Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon Percutaneous Transluminal Angioplasty (PTA) Catheter for Treatment of Below-the-Knee (BTK) Arteries 39
Lutonix 014 DCB Catheter - A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-knee (BTK) Arteries (Lutonix BTK Trial) 39
Lutonix 014 DCB Catheter - Drug Eluting Balloon in Peripheral Intervention for Below-the-knee Arteries with Freeway and Lutonix 40
Lutonix 014 DCB Catheter - Evaluation of Paclitaxel in Patients with CLI (Critical Limb Ischemia) and Femoropopliteal Occlusive Disease Treated with DCB Angioplasty 40
Lutonix 014 DCB Catheter - Tack Optimized Balloon Angioplasty Study for Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System 40
LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - Product Status 41
LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - Product Description 41
LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions 42
Marquee - Product Status 43
Marquee - Product Description 43
Minimally Invasive Cutting Instrumentation - Product Status 44
Minimally Invasive Cutting Instrumentation - Product Description 44
New Fixation Device - Product Status 45
New Fixation Device - Product Description 45
New Hemostat 1 - Product Status 46
New Hemostat 1 - Product Description 46
New Hemostat 2 - Product Status 47
New Hemostat 2 - Product Description 47
Next-generation Radiation Therapy - Product Status 48
Next-generation Radiation Therapy - Product Description 48
Phasix Expansion - Product Status 49
Phasix Expansion - Product Description 49
PowerPort - Low-Profile Version - Product Status 50
PowerPort - Low-Profile Version - Product Description 50
Progel Dural Sealant - Product Status 51
Progel Dural Sealant - Product Description 51
Progel Emerald - Product Status 52
Progel Emerald - Product Description 52
ProGEL-VS - Product Status 53
ProGEL-VS - Product Description 53
Restore Suturing System - Product Status 54
Restore Suturing System - Product Description 54
RFID Tag Device - Product Status 55
RFID Tag Device - Product Description 55
RFID Tag Device - A Prospective, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Performance of the Health Beacons Radiofrequency Identification (RFID) Localization System for Marking and Retrieving Non-palpable Breast Lesions 56
sideKicK Side Branch Protection System - Product Status 57
sideKicK Side Branch Protection System - Product Description 57
Transformational Fixation - Product Status 58
Transformational Fixation - Product Description 58
Tridyne Peripheral - Product Status 59
Tridyne Peripheral - Product Description 59
Ultrascore - Product Status 60
Ultrascore - Product Description 60
Venovo PTA Catheter - Product Status 61
Venovo PTA Catheter - Product Description 61
VENOVO Venous Stent - Product Status 62
VENOVO Venous Stent - Product Description 62
VIVEXX Carotid Stent - Product Status 63
VIVEXX Carotid Stent - Product Description 63
XenMatrix AB LX - Product Status 64
XenMatrix AB LX - Product Description 64
C. R. Bard Inc, Key Employees 66
C. R. Bard Inc, Key Employee Biographies 68
C. R. Bard Inc, Other Locations 69
C. R. Bard Inc, Subsidiaries 69
C. R. Bard Inc, Business Unit 73
Glossary 81
List of Figures
C. R. Bard Inc Pipeline Products by Equipment Type 9
C. R. Bard Inc Pipeline Products by Development Stage 14
C. R. Bard Inc Ongoing Clinical Trials by Trial Status 17
